---
title: "Mobia Medical, Inc. (MOBI.US)"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/MOBI.US.md"
symbol: "MOBI.US"
name: "Mobia Medical, Inc."
industry: "醫療器械"
datetime: "2026-05-16T03:16:42.704Z"
locales:
  - [en](https://longbridge.com/en/quote/MOBI.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MOBI.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MOBI.US.md)
---

# Mobia Medical, Inc. (MOBI.US)

## 公司概況

Mobia Medical, Inc. 開發和商業化神經刺激醫療設備，包括用于中風康复和其他神經系統疾病的植入系統。該公司提供結合迷走神經刺激與治療的神經刺激系統和設備，以應對慢性神經系統疾病。其主要產品 Vivistim System 是一種獲得 FDA 批準的植入設備，旨在幫助中風后患者的上肢運動功能康复

| 項目 | 詳情 |
|------|--------|
| 行業 | 醫療器械 |
| 交易所 | US Market |
| 官網 | [www.mobia.com](https://www.mobia.com) |

## 關鍵驅動因素
> *AI 分析的影響該股票表現的關鍵因素*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Longbridge 獨家多因子評級模型*
> 更新時間: 2026-05-15T04:30:13.000Z

**綜合: B (0.26)**

**行業**: 醫療器械

| 指標 | 數值 |
|--------|-------|
| 行業排名 | 32 / 183 |
| 行業中位數 | C |
| 行業均值 | C |

- **風格**: 平衡型 - 公司有成長期業務也有成熟期業務的股票。
- **規模**: 小盤型 - 公司經營有較高的成長性和波動性，易於獲得較高的投資收益。

**綜合評分**: B

#### 風格得分 評分: 

| 指標 | 數值 | 評級 |
|-----------|-------|--------|
| 營業收入同比 | 104.81% |  |
| 凈利潤同比 | -88.99% |  |
| 市凈率 | -2.64 |  |
| 股息率 | 0.00% |  |

#### 規模得分 評分: 

| 指標 | 數值 | 評級 |
|-----------|-------|--------|
| 市值 | 398678961.55 |  |
| 營業收入 | 32040978.00 |  |

#### 多維評分 評分: B

| 指標 | 數值 | 評級 |
|-----------|-------|--------|
| 凈資產收益率（ROE） | 36.21% | A |
| 凈利率 | -145.12% | E |
| 毛利率 | 81.07% | A |
| 營業收入同比 | 104.81% | A |
| 凈利潤同比 | -88.99% | E |
| 總資產同比 | 117.96% | A |
| 凈資產同比 | 229.92% | A |
| 現金流凈利率 | 98.27% | C |
| 運營現金流同比 | 104.81% | A |
| 資產周轉率 | 0.91 | A |
| 資產負債率 | 39.77% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Mobia Medical, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "風格得分",
      "grade": "",
      "indicators": [
        {
          "name": "營業收入同比",
          "value": "104.81%",
          "rating": ""
        },
        {
          "name": "凈利潤同比",
          "value": "-88.99%",
          "rating": ""
        },
        {
          "name": "市凈率",
          "value": "-2.64",
          "rating": ""
        },
        {
          "name": "股息率",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "規模得分",
      "grade": "",
      "indicators": [
        {
          "name": "市值",
          "value": "398678961.55",
          "rating": ""
        },
        {
          "name": "營業收入",
          "value": "32040978.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "多維評分",
      "grade": "B",
      "indicators": [
        {
          "name": "凈資產收益率（ROE）",
          "value": "36.21%",
          "rating": "A"
        },
        {
          "name": "凈利率",
          "value": "-145.12%",
          "rating": "E"
        },
        {
          "name": "毛利率",
          "value": "81.07%",
          "rating": "A"
        },
        {
          "name": "營業收入同比",
          "value": "104.81%",
          "rating": "A"
        },
        {
          "name": "凈利潤同比",
          "value": "-88.99%",
          "rating": "E"
        },
        {
          "name": "總資產同比",
          "value": "117.96%",
          "rating": "A"
        },
        {
          "name": "凈資產同比",
          "value": "229.92%",
          "rating": "A"
        },
        {
          "name": "現金流凈利率",
          "value": "98.27%",
          "rating": "C"
        },
        {
          "name": "運營現金流同比",
          "value": "104.81%",
          "rating": "A"
        },
        {
          "name": "資產周轉率",
          "value": "0.91",
          "rating": "A"
        },
        {
          "name": "資產負債率",
          "value": "39.77%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## 估值分析

| 指標 | 當前值 | 行業排名 | 最高 | 中位 | 最低 |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -8.47 | 141/183 | - | - | - |
| PB | -2.61 | 159/183 | - | - | - |
| PS (TTM) | 12.29 | 118/183 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## 同業比較

| 排名 | 名稱 | 盈利 | 成長 | 營運 | 財務安全 | 現金流 | 評級 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | 直覺外科 (ISRG.US) | A | B | C | A | B | B |
| 04 | 史賽克 (SYK.US) | A | C | C | C | B | B |
| 05 | 波士頓科學 (BSX.US) | A | B | C | C | B | B |

## 參考連結

- [公司概況 — 簡介、高管、股東、業務構成](https://longbridge.com/zh-HK/quote/MOBI.US/overview.md)
- [財務報表 — 損益表、資產負債表、現金流、分紅方案](https://longbridge.com/zh-HK/quote/MOBI.US/norm.md)
- [相關新聞](https://longbridge.com/zh-HK/quote/MOBI.US/news.md)
- [公告 — 公司公告與監管文件](https://longbridge.com/zh-HK/quote/MOBI.US/filings.md)

---

> **免責聲明: 本文僅供參考，不構成任何投資建議。**